LeMaitre Vascular, Inc. logo LMAT - LeMaitre Vascular, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 14
HOLD 6
SELL 0
STRONG
SELL 0
| PRICE TARGET: $127.50 DETAILS
HIGH: $135.00
LOW: $120.00
MEDIAN: $127.50
CONSENSUS: $127.50
UPSIDE: 30.43%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Platform & Compounding FCF 65% confidence

Primary model: Two-stage FCF DCF

Valuation Signal Fair Value Moderate
Trading 16.8% below fair value
Current Price $97.75
Bear Case $76.61 21.6% downside ($76.61 - $97.75) / $97.75 = -21.6% 9% stage 1 growth, 11% discount
Fair Value $117.51 20.2% upside ($117.51 - $97.75) / $97.75 = 20.2% 16% stage 1 growth, 11% discount
Bull Case $163.71 67.5% upside ($163.71 - $97.75) / $97.75 = 67.5% 20% stage 1 growth, 11% discount

Adjust Assumptions

15.5%
11.0%
3.0%

Key Value Driver

FCF growth rate (16% base case)

Terminal Value % of EV 43%
Implied Market Multiple 27.7x

Plain-Language Summary

Our base-case estimate uses a two-stage discounted cash flow model based on free cash flow. We then blend that result with the average analyst price target of $127.50 from 20 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $117.51 per share.

Key Risks

  • P/E alone misleads — earnings depressed by growth investment
  • Cyclical or commodity businesses may be misclassified as platforms
  • Terminal value dominance suggests sensitivity to long-run assumptions